Miriam Kidron, Chief Scientific Officer at ORAMED PHARMACEUTICALS INC. (ORMP), sold 89,636 shares at $8.50 ($762K) on 2017-08-02, disclosed to the SEC on 2017-08-03.
Open-market sale of $762k ORMP by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ORMP | SELL | 2015-12-31 | $445K | — | Filing → |
| ORMP | SELL | 2014-09-12 | $267K | — | Filing → |
| ORMP | SELL | 2014-04-03 | $1.7M | — | Filing → |